Investigational Drug Information for Edivoxetine
✉ Email this page to a colleague
What is the development status for investigational drug Edivoxetine?
Edivoxetine is an investigational drug.
There have been 11 clinical trials for Edivoxetine.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Eli Lilly and Company and [disabled in preview].
Summary for Edivoxetine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 46 |
| WIPO Patent Applications | 28 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 3 (2011-03-01) |
| Vendors | 16 |
Recent Clinical Trials for Edivoxetine
| Title | Sponsor | Phase |
|---|---|---|
| A Study of LY2216684 in Participants With Major Depression Disorder | Eli Lilly and Company | Phase 3 |
| A Study of LY2216684 in Healthy Participants | Eli Lilly and Company | Phase 1 |
| A Study in Prevention of Re-emergence of Depression Symptoms | Eli Lilly and Company | Phase 3 |
Clinical Trial Summary for Edivoxetine
Top disease conditions for Edivoxetine
Top clinical trial sponsors for Edivoxetine
US Patents for Edivoxetine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
